Home   |   Products   |   Store Locator
  • Products A-Z
  • New Products
  • JarrowProbiotics.com

Reading Material

About Us

Retailers

Wholesale Applications

Wholesale Orders

orders@jarrow.com
(310) 204-6936

MK-7

Bone & Cardiovascular Health*  

MK-7

Product Data

Serving: 90 mcg
Size: 60 Softgels
Product Number: 130001
Product Code: MK7


PRODUCT HIGHLIGHTS

  • Vitamin K2 as Menaquinone-7 Softgels
  • K2 More Useful Than K1
    • K2 has longer half-life (days vs. hours)
    • K2 has higher activity (6X in vitro)
  • 90 mcg Per Serving
  • Critical to Blood Clotting & Coagulation

What does MK-7 do?

Jarrow FORMULAS® MK-7 is an extract from genetically unmodified (non-GMO) soybeans fermented with Bacillus subtilus natto. MK-7 (Menaquinone-7) is an enhanced bioactive form of vitamin K2 from Natto that is ten times better absorbed than K1 from spinach. MK-7 is responsible for the carboxylation of specific bone proteins needed for building bone.* Also, MK-7 promotes cardiovascular health by helping to maintain arterial elasticity.*

Keep out of the reach of children.



*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Suggested Usage

Take 1 softgel per day, or as directed by your qualified health care consultant.

NOTE: If you have a medical condition, are pregnant, lactating, or trying to conceive, are under the age of 18, or are taking medications (especially anticoagulants [e.g. warfarin/Coumadin]), consult your health care practitioner before using this product.

Other Ingredients

Medium chain triglycerides, evening primrose oil, beeswax and lecithin. Softgel consists of gelatin, water, glycerin and caramel (as a light barrier).

Contains: Soy.

No wheat, no gluten, no dairy, no egg, no fish/shellfish, no peanuts/tree nuts.

You May Also Be Interested In

Bone-Up Bone-Up (Vegetarian) Glucosamine + Chondroitin + MSM Venous PF

Reformulation: 01/01/2007 | Design Change: 01/01/2007 | Text Revision: 11/17/2009